NADA, Elisabetta
NADA, Elisabetta
SCIENZE CHIRURGICHE
Hepatic fibrosis of any origin in a large population of type 2 diabetes patients
2021-01-01 Giorda CB, Picariello R, Tartaglino B, Nada E, Linzalata C, Romeo F, Costa G, Gnavi R
Metabolic Syndrome after liver transplantation: have risk factors changed over time?
2015-01-01 Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E.
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant
2014-01-01 F. Tandoi; E. Nada; F. Pittaluga; F. Fop; F. Lupo; R. Romagnoli; M. Salizzoni
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION
2015-01-01 Lupo, Francesco; Tandoi, Francesco; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Patrono, Damiano; Galasso, Erica; Mirabella, Stefano; Cocchis, Donatella; Romagnoli, Renato; Salizzoni, Mauro
Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in De-Novo Liver Transplantation
2015-01-01 Lupo, Francesco; Tandoi, Francesco; Patrono, Damiano; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Galasso, Erica; Romagnoli, Renato; Salizzoni, Mauro
Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection
2012-01-01 F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni
Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity
2012-01-01 F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni
RELATIONSHIP BETWEEN LIVER GRAFT STEATOSIS, VIRAL RECURRENCE AND POST-LIVER TRANSPLANTATION SURVIVAL IN HEPATITIS C VIRUS POSITIVE RECIPIENTS
2013-01-01 Nada, Elisabetta; Mirabella, Stefano; Tandoi, Francesco; Romagnoli, Renato; David, Ezio; Lupo, Francesco; Patrono, Damiano; Salizzoni, Mauro
Risk factors for arterial hypertension after liver transplantation
2018-01-01 Di Stefano, Cristina*; Vanni, Ester; Mirabella, Stefano; Younes, Ramy; Boano, Valentina; Mosso, Elena; Nada, Elisabetta; Milazzo, Valeria; Maule, Simona; Romagnoli, Renato; Salizzoni, Mauro; Veglio, Franco; Milan, Alberto
Risk factors for metabolic syndrome after liver transplantation: what has changed over time
2015-01-01 Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Mezzabotta, L.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E.
USE OF GRAFTS FROM HEPATITIS C VIRUS POSITIVE DONORS IN LIVER TRANSPLANTATION: OUTCOMES UNDER CURRENT SELECTION CRITERIA
2013-01-01 Tandoi, Francesco; Romagnoli, Renato; Lupo, Francesco; Nada, Elisabetta; Patrono, Damiano; Mirabella, Stefano; Salizzoni, Mauro
Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation
2019-01-01 Patrono D.; Franchi E.; Guarasci F.; Bartoli G.; Nada E.; Rigo F.; Ottobrelli A.; Fonio P.; Salizzoni M.; Romagnoli R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Hepatic fibrosis of any origin in a large population of type 2 diabetes patients | 2021 | Giorda CB, Picariello R, Tartaglino B, Nada E, Linzalata C, Romeo F, Costa G, Gnavi R | |
| Metabolic Syndrome after liver transplantation: have risk factors changed over time? | 2015 | Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E. | |
| Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant | 2014 | F. Tandoi; E. Nada; F. Pittaluga; F. Fop; F. Lupo; R. Romagnoli; M. Salizzoni | |
| ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION | 2015 | Lupo, Francesco; Tandoi, Francesco; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Patrono, Damiano; Galasso, Erica; Mirabella, Stefano; Cocchis, Donatella; Romagnoli, Renato; Salizzoni, Mauro | |
| Once-Daily Prolonged-Release Tacrolimus Versus Twice-Daily Tacrolimus in De-Novo Liver Transplantation | 2015 | Lupo, Francesco; Tandoi, Francesco; Patrono, Damiano; Mazza, Elena; Catalano, Giorgia; Nada, Elisabetta; Galasso, Erica; Romagnoli, Renato; Salizzoni, Mauro | |
| Outcomes of Liver Transplantation from Hepatitis B CoreAntibody–Positive Donors in Viral Cirrhosis Patients: The PrevailingNegative Effect of Recipient Hepatitis C Virus Infection | 2012 | F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni | |
| Outcomes of Liver Transplantation in Simultaneously Hepatitis BSurface Antigen and Hepatitis C Virus RNA Positive Recipients: TheDeleterious Effect of Donor Hepatitis B Core Antibody Positivity | 2012 | F.Tandoi; R.Romagnoli; S.Martini; E.Mazza; E.Nada; D.Cocchis; F.Lupo; M.Salizzoni | |
| RELATIONSHIP BETWEEN LIVER GRAFT STEATOSIS, VIRAL RECURRENCE AND POST-LIVER TRANSPLANTATION SURVIVAL IN HEPATITIS C VIRUS POSITIVE RECIPIENTS | 2013 | Nada, Elisabetta; Mirabella, Stefano; Tandoi, Francesco; Romagnoli, Renato; David, Ezio; Lupo, Francesco; Patrono, Damiano; Salizzoni, Mauro | |
| Risk factors for arterial hypertension after liver transplantation | 2018 | Di Stefano, Cristina*; Vanni, Ester; Mirabella, Stefano; Younes, Ramy; Boano, Valentina; Mosso, Elena; Nada, Elisabetta; Milazzo, Valeria; Maule, Simona; Romagnoli, Renato; Salizzoni, Mauro; Veglio, Franco; Milan, Alberto | |
| Risk factors for metabolic syndrome after liver transplantation: what has changed over time | 2015 | Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Mezzabotta, L.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E. | |
| USE OF GRAFTS FROM HEPATITIS C VIRUS POSITIVE DONORS IN LIVER TRANSPLANTATION: OUTCOMES UNDER CURRENT SELECTION CRITERIA | 2013 | Tandoi, Francesco; Romagnoli, Renato; Lupo, Francesco; Nada, Elisabetta; Patrono, Damiano; Mirabella, Stefano; Salizzoni, Mauro | |
| Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation | 2019 | Patrono D.; Franchi E.; Guarasci F.; Bartoli G.; Nada E.; Rigo F.; Ottobrelli A.; Fonio P.; Salizzoni M.; Romagnoli R. |